Strategic Partnerships Identify potential co-development and integration opportunities with pharmaceutical and device companies focusing on injectable medications, such as Haselmeier and Welkin Health, to expand Gocap compatibility and build a broader smart pen ecosystem.

Regulatory Readiness Leverage ISO 13485 certification to position Gocap as a compliant safety and data-tracking solution for global markets, targeting medical device manufacturers seeking QMS-aligned partners for smart injector monitoring components.

Data Enablement Emphasize the value of automated drug-delivery data to life sciences customers by offering analytics, adherence insights, and integration-ready APIs to connect to EHRs and mobile apps for enhanced patient outcomes.

Market Entry Capitalize on the rising focus on digital health and adherence by pursuing early pilots with small-to-mid tier device makers and diabetes/care management platforms to validate Gocap’s impact before broader scale.

Financial & Growth Highlight a proof-based value proposition with scalable pricing for small teams, aiming to convert from pilot programs to multi-year contracts as revenue scales beyond the current mid single-digit million range.